Jana Jeschke

2.0k total citations
22 papers, 1.3k citations indexed

About

Jana Jeschke is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jana Jeschke has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Jana Jeschke's work include Epigenetics and DNA Methylation (18 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (5 papers). Jana Jeschke is often cited by papers focused on Epigenetics and DNA Methylation (18 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (5 papers). Jana Jeschke collaborates with scholars based in United States, Belgium and Netherlands. Jana Jeschke's co-authors include Alexander Koch, Wim Van Criekinge, Tim De Meyer, Manon van Engeland, Nita Ahuja, Stephen B. Baylin, François Fuks, James G. Herman, Leander Van Neste and Évelyne Collignon and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Reviews Molecular Cell Biology.

In The Last Decade

Jana Jeschke

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jana Jeschke United States 16 958 422 394 308 165 22 1.3k
Habib Hamidi United States 16 685 0.7× 310 0.7× 335 0.9× 437 1.4× 104 0.6× 41 1.2k
Rachel Bikoff United States 5 865 0.9× 334 0.8× 315 0.8× 247 0.8× 85 0.5× 7 1.3k
Martina Kluth Germany 22 768 0.8× 415 1.0× 644 1.6× 327 1.1× 98 0.6× 75 1.3k
Miguel Quintela-Fandiño Spain 21 653 0.7× 432 1.0× 223 0.6× 452 1.5× 114 0.7× 64 1.2k
Alexander Koch Belgium 18 1.5k 1.5× 565 1.3× 505 1.3× 322 1.0× 111 0.7× 30 1.9k
Eeva Kettunen Finland 19 884 0.9× 440 1.0× 441 1.1× 374 1.2× 159 1.0× 36 1.6k
Salahaldin A. Tahir United States 20 900 0.9× 533 1.3× 375 1.0× 526 1.7× 106 0.6× 26 1.9k
Naofumi Kagara Japan 21 673 0.7× 739 1.8× 220 0.6× 637 2.1× 251 1.5× 65 1.6k
Pien M. Delis‐van Diemen Netherlands 20 660 0.7× 295 0.7× 146 0.4× 388 1.3× 196 1.2× 35 1.1k
Yekaterina B. Khotskaya United States 14 615 0.6× 420 1.0× 213 0.5× 288 0.9× 112 0.7× 18 1.0k

Countries citing papers authored by Jana Jeschke

Since Specialization
Citations

This map shows the geographic impact of Jana Jeschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Jeschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Jeschke more than expected).

Fields of papers citing papers by Jana Jeschke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Jeschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Jeschke. The network helps show where Jana Jeschke may publish in the future.

Co-authorship network of co-authors of Jana Jeschke

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Jeschke. A scholar is included among the top collaborators of Jana Jeschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Jeschke. Jana Jeschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeschke, Jana, et al.. (2022). Why novel mRNA modifications are so challenging and what we can do about it. Nature Reviews Molecular Cell Biology. 23(6). 385–386. 10 indexed citations
2.
Koch, Alexander, Jana Jeschke, Wim Van Criekinge, Manon van Engeland, & Tim De Meyer. (2019). MEXPRESS update 2019. Nucleic Acids Research. 47(W1). W561–W565. 191 indexed citations
3.
Jeschke, Jana, Martin Bizet, Christine Desmedt, et al.. (2017). DNA methylation–based immune response signature improves patient diagnosis in multiple cancers. Journal of Clinical Investigation. 127(8). 3090–3102. 110 indexed citations
4.
Chiappinelli, Katherine B., Angela A. Guzzetta, Anup Sharma, et al.. (2017). Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells. PLoS ONE. 12(6). e0179501–e0179501. 71 indexed citations
5.
Vlodrop, Iris J.H. van, Sophie C. Joosten, Tim De Meyer, et al.. (2016). A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients. Clinical Cancer Research. 23(8). 2006–2018. 44 indexed citations
6.
Jeschke, Jana, Évelyne Collignon, & François Fuks. (2016). Portraits of TET-mediated DNA hydroxymethylation in cancer. Current Opinion in Genetics & Development. 36. 16–26. 51 indexed citations
7.
Deckers, Ivette A.G., Leo J. Schouten, Leander Van Neste, et al.. (2015). Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome. Clinical Cancer Research. 21(15). 3492–3500. 49 indexed citations
8.
Calmon, Marília Freitas, Jana Jeschke, Wei Zhang, et al.. (2015). Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer. Epigenetics. 10(7). 622–632. 35 indexed citations
9.
Koch, Alexander, Tim De Meyer, Jana Jeschke, & Wim Van Criekinge. (2015). MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics. 16(1). 636–636. 278 indexed citations
10.
Delatte, Benjamin, Jana Jeschke, Matthieu Defrance, et al.. (2015). Genome-wide hydroxymethylcytosine pattern changes in response to oxidative stress. Scientific Reports. 5(1). 12714–12714. 48 indexed citations
11.
Guzzetta, Angela A., Tao Fu, Jinming Chen, et al.. (2014). CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomas. Epigenetics. 9(5). 738–746. 5 indexed citations
12.
Jeschke, Jana, Évelyne Collignon, & François Fuks. (2014). DNA methylome profiling beyond promoters – taking an epigenetic snapshot of the breast tumor microenvironment. FEBS Journal. 282(9). 1801–1814. 23 indexed citations
13.
Jeschke, Jana, Heather M. O’Hagan, Wei Zhang, et al.. (2013). Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines. Clinical Cancer Research. 19(12). 3201–3211. 68 indexed citations
14.
Cello, Francescopaolo Di, Leslie Cope, Huili Li, et al.. (2013). Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer. PLoS ONE. 8(7). e68630–e68630. 44 indexed citations
15.
Fu, Tao, Emmanouil P. Pappou, Angela A. Guzzetta, et al.. (2012). CpG Island Methylator Phenotype–Positive Tumors in the Absence of MLH1 Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis. Clinical Cancer Research. 18(17). 4743–4752. 41 indexed citations
16.
Jeschke, Jana, Leander Van Neste, Sabine C. Glöckner, et al.. (2012). Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen. Epigenetics. 7(7). 701–709. 56 indexed citations
17.
Fu, Tao, Angela A. Guzzetta, Jana Jeschke, et al.. (2012). KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma. International Journal of Cancer. 132(11). 2502–2509. 12 indexed citations
18.
Jeschke, Jana, Heather M. O’Hagan, Wei Zhang, et al.. (2012). Abstract 94: Epigenetic silencing of CDO1 sustains viability of breast cancer cells via the reduction of cellular ROS. Cancer Research. 72(8_Supplement). 94–94. 1 indexed citations
19.
Yi, Joo Mi, Mashaal Dhir, Leander Van Neste, et al.. (2011). Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer. Clinical Cancer Research. 17(6). 1535–1545. 118 indexed citations
20.
Dhir, Mashaal, Shinichi Yachida, Leander Van Neste, et al.. (2010). Sessile serrated adenomas and classical adenomas: An epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract. International Journal of Cancer. 129(8). 1889–1898. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Habib Hamidi Breakdown of academic impact, for papers by Rachel Bikoff Breakdown of academic impact, for papers by Martina Kluth Breakdown of academic impact, for papers by Miguel Quintela-Fandiño Breakdown of academic impact, for papers by Alexander Koch Breakdown of academic impact, for papers by Eeva Kettunen Breakdown of academic impact, for papers by Salahaldin A. Tahir Breakdown of academic impact, for papers by Naofumi Kagara Breakdown of academic impact, for papers by Pien M. Delis‐van Diemen Breakdown of academic impact, for papers by Yekaterina B. Khotskaya
Rankless by CCL
2026